composition-dependent in vivo antitumor activity of adriamycin-conjugated polymeric micelle against murine colon adenocarcinoma 26

References

• Beatty B. G., Beatty J. D., Williams L. E., Paxton R. J., Shively J. E., O'Conner-Tressel M. Effect of specific antibody pretreatment on liver uptake of 111-In labeled anti-carcinoembryonic antigen monoclonal antibody in nude mice bearing human colon cancer xenografts. Cancer Res. 1989; 49: 1587–1594
   PubMed Web of Science ®Google Scholar
• McCready D. R., Balch C. M., Fidler I. J., Murray J. L. Lack of comparability between binding of monoclonal antibodies to melanoma cells in vitro and localization in vivo. J. Natl. Cancer Inst. 1989; 81: 682–686
   PubMed Web of Science ®Google Scholar
• Fujimoto K., Covell D. G., Fletcher J. E., Weinstein N. Modeling analysis of the global and microscopic distribution of immunoglobulin G, F(ab')2, and Fab in tumors. Cancer Res. 1989; 49: 5656–5663
   PubMed Web of Science ®Google Scholar
• Jain R. K. Delivery of novel therapeutic agents in tumors: Physiological barriers and strategies. J Natl. Cancer Inst. 1989; 81: 54–60
   Google Scholar
• Endo N., Umemoto N., Kato Y., Takeda Y., Hara T. A novel covalent modification of antibodies at their amino groups with retention of antibodies at their amino groups with retention of antigen-binding activity. J. Immunol. Methods 1987; 104: 253–258
   PubMed Web of Science ®Google Scholar
• Davis S. S., Illum L. Colloidal delivery systems-Opportunities and challenges. “Site-Specific Drug Delivery”, E. Tomlinson, S. S. Davis. Wiley, Lancing, Sussex 1986; 93–110
   Google Scholar
• Gregoriadis G., Senior J., Wolff B., Kirby C. Fate of liposomes in vivo: Control leading to targeting. “Receptor-Mediated Targeting of Drugs”, G. Gregoriadis, G. Poste, J. Senior, A. Trouet. Plenum Press, New York 1984; 243–266
   Google Scholar
• Allen T. M., Chonn A. Large unilamellar liposomes with low uptake into the reticuloendothelial system. FEES Lett. 1987; 223: 42–86
   PubMed Web of Science ®Google Scholar
• Gabizon A., Papahadjopoulos D. Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. Proc. Natl. Acad. Sci. USA 1988; 85: 6949–6953
   PubMed Web of Science ®Google Scholar
• Duncan R., Kopeckova-Rejmanova P., Strohalm J., Hume I., Cable H. C., Pohl J., Lloyd J. B., Kopecek J. Anti-cancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. I. Evaluation of daunomycin and puromycin conjugates in vitro. Br. J. Cancer 1987; 55: 165–174
   PubMed Web of Science ®Google Scholar
• Hoes C. J. T., Potman W., van Heeswijk W. A. R., Mud J., de Grooth B. G., Grave J., Feijen J. Optimization of macromolecular prodrugs of the antitumor antibiotic adriamycin. J. Controlled Release 1985; 2: 205–213
   Google Scholar
• Zunino Pratesi G., Micheloni A. Poly(carboxylic acid) polymers as carriers for anthracyclines. J. Controlled Release 1989; 10: 65–73, Description was made in Table 2
   Web of Science ®Google Scholar
• Yokoyama M., Miyauchi M., Yamada N., Okano T., Sakurai Y., Kataoka K., Inoue S. Characterization and anticancer activity of the micelle-forming polymeric anticancer drug Adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer. Cancer Res. 1990; 50: 1693–1700
   PubMed Web of Science ®Google Scholar
• Yokoyama M., Miyauchi M., Yamada N., Okano T., Sakurai Y., Kataoka K., Inoue S. Polymer micelles as novel carrier: Adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer. J. Controlled Release 1990; 11: 269–278
   Web of Science ®Google Scholar
• Duncan R., Hume I. C., Kopecková P., Ulbrich K., Strohalm J., Kopecek J. Anticancer agents coupled to N-(2-hydroxypropyl) methacrylamide copolymers. 3. Evaluation of Adriamycin conjugates against mouse leukemia L1210 in vivo. J. Controlled Release 1989; 10: 51–63
   Web of Science ®Google Scholar
• Pratesi G., Savi G., Pezzoni G., Bellini O., Penco S., Tinelli S., Zunino F. Poly-L-aspartic acid as a carrier for doxorubicin: A comparative in vivo study of free and polymer-bound drug. Br. J. Cancer 1985; 52: 841–848
   PubMed Web of Science ®Google Scholar
• Yang H. M., Reisfeld R. A. Doxorubicin conjugated with a monoclonal antibody directed to a human melanoma-associated proteoglycan suppresses the growth of established tumor xenografts in nude mice. Proc. Natl. Acad. Sci. USA 1988; 85: 1189–1193
   PubMed Web of Science ®Google Scholar
• Shouval D., Adler R., Wands J. R., Hurwitz E., Isselbacher K. J., Sela M. Doxorubicin conjugates of monoclonal antibodies to hepatoma-associated antigens. Proc. Natl. Acad. Sci. USA 1988; 85: 8276–8280
   PubMed Web of Science ®Google Scholar
• Dillman D. O., Shawier D. L., Johnson D. E., Meyer D. L., Koziol J. A., Frincke J. M. Preclinical trials with combinations and conjugates of T101 monoclonal antibody and doxorubicin. Cancer Res. 1986; 46: 4886–4891
   PubMed Web of Science ®Google Scholar
• De Flola A., Benatti U., Guida L., Zocchi E. Encapsulation of Adriamycin in human erythrocytes. Proc. Natl. Acad. Sci. USA 1986; 83: 7029–7033
   PubMed Web of Science ®Google Scholar
• Mayer L. D., Tai L. C. L., Ko D. S. C., Masin D., Ginsberg R. S., Cullins P. R., Bally M. B. Influence of vesicle size, lipid composition, and drug-to-lipid ratio on the biological activity of liposomal doxorubicin in mice. Cancer Res. 1989; 49: 5922–5930
   PubMed Web of Science ®Google Scholar
• Astier A., Doat B., Ferrer M.-J., Benoit G., Fleury J., Rolland A., Leverge R. Enhancement of Adriamycin anti-tumor activity by its binding with an intracellular sustained-release form, polymethacrylate nanospheres, in U-937 cells. Cancer Res. 1988; 48: 1835–1841
   PubMed Web of Science ®Google Scholar
• Yokoyama M., Okano T., Sakurai Y., Ekimoto H., Shibazaki C., Kataoka K. Toxicity and antitumor activity against solid tumors of micelle-forming polymeric anticancer drug and its extremely long circulation in blood. Cancer Res. 1991; 51: 3229–3236
   PubMed Web of Science ®Google Scholar
• Yokoyama M., Inoue S., Kataoka K., Yui N., Sakurai Y. Preparation of Adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer. Makromol. Chem. Rapid Commun. 1987; 8: 431–435
   Google Scholar
• Yokoyama M., Inoue S., Kataoka K., Yui N., Okano T., Sakurai Y. Molecular design for missile drug: Synthesis of Adriamycin conjugated with IgG using poly(ethylene glycol)-poly(aspartic acid) block copolymer as intermediate carrier. Makromol. Chem. 1989; 190: 2041–2054
   Web of Science ®Google Scholar
• Yokoyama M., Kwon G. S., Okano T., Sakurai Y., Seto T., Kataoka K. Preparation of micelle-forming polymer-drug conjugates. Bioconjugate Chem. 1992; 3: 295–301
   PubMed Web of Science ®Google Scholar
• Tanaka Y., Eda H., Tanaka T., Udagawa T., Ishikawa T., Horii I., Ishitsuka H., Kataoka T., Taguchi T. Experimental cancer cachexia induced by transplantable colon 26 adenocarcinoma in mice. Cancer Res. 1990; 50: 2290–2295
   PubMed Web of Science ®Google Scholar
• Arcamono F. Analogues modified in ring A substitution. “Doxorubicin: Anticancer Antibiotics,”. Academic Press, London 1981; 163–195
   Google Scholar
• Arcamono F. Analogues modified in the aminosugar residue. “Doxorubicin: Anticancer Antibiotics,”. Academic Press, London 1981; 196–258
   Google Scholar
• Barbieri B., Giuliani F. C., Bordoni T., Casazza A. M., Geroni C., Bellini O., Suarato A., Gioia B., Penco S., Arcamone F. Chemical and biological characterization of 4′-iodo-4′-deoxydoxorubicin. Cancer Res. 1987; 47: 4001–4006
   PubMed Web of Science ®Google Scholar
• Tsuruo T., Iida H., Tsukagoshi S., Sakurai Y. 4′-O-Tetrahydropyranyladriamycin as a potential new antitumor agent. Cancer Res. 1982; 42: 1462–1467
   PubMed Web of Science ®Google Scholar
• Tsuruo T., Yusa K., Sudo Y., Takamori R., Sugimoto Y. A fluorine-containing anthracycline (ME2303) as a new antitumor agent against murine and human tumors and their multidrug-resistant sublines. Cancer Res. 1989; 49: 5537–5542
   PubMed Web of Science ®Google Scholar
• Atsumi R., Endo K., Kakutani T., Takakura Y., Hashida M., Sezaki H. Disposition characteristics of mitomycin C-dextran conjugate in normal and tumor-bearing muscles of rabbits. Cancer Res. 1987; 47: 5546–5551
   PubMed Web of Science ®Google Scholar